The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Guaifenesin 200 mg syrup in sachet

Johnson & Johnson (Ireland) LimitedPA0330/059/001

Main Information

Trade NameGuaifenesin 200 mg syrup in sachet
Active SubstancesGuaifenesin
Dosage FormSyrup in sachet
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/059/001

Group Information

ATC CodeR05CA03 guaifenesin


License statusAuthorised
Licence Issued28/01/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back